These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 15733558)

  • 1. Sensory nerve desensitization by resiniferatoxin improves glucose tolerance and increases insulin secretion in Zucker Diabetic Fatty rats and is associated with reduced plasma activity of dipeptidyl peptidase IV.
    Gram DX; Hansen AJ; Deacon CF; Brand CL; Ribel U; Wilken M; Carr RD; Svendsen O; Ahrén B
    Eur J Pharmacol; 2005 Feb; 509(2-3):211-7. PubMed ID: 15733558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma calcitonin gene-related peptide is increased prior to obesity, and sensory nerve desensitization by capsaicin improves oral glucose tolerance in obese Zucker rats.
    Gram DX; Hansen AJ; Wilken M; Elm T; Svendsen O; Carr RD; Ahrén B; Brand CL
    Eur J Endocrinol; 2005 Dec; 153(6):963-9. PubMed ID: 16322403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sensory nerve inactivation by resiniferatoxin improves insulin sensitivity in male obese Zucker rats.
    Moesgaard SG; Brand CL; Sturis J; Ahrén B; Wilken M; Fleckner J; Carr RD; Svendsen O; Hansen AJ; Gram DX
    Am J Physiol Endocrinol Metab; 2005 Jun; 288(6):E1137-45. PubMed ID: 15883192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic inhibition of circulating dipeptidyl peptidase IV by FE 999011 delays the occurrence of diabetes in male zucker diabetic fatty rats.
    Sudre B; Broqua P; White RB; Ashworth D; Evans DM; Haigh R; Junien JL; Aubert ML
    Diabetes; 2002 May; 51(5):1461-9. PubMed ID: 11978643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvement of glucose tolerance in Zucker diabetic fatty rats by long-term treatment with the dipeptidyl peptidase inhibitor P32/98: comparison with and combination with rosiglitazone.
    Wargent E; Stocker C; Augstein P; Heinke P; Meyer A; Hoffmann T; Subramanian A; Sennitt MV; Demuth HU; Arch JR; Cawthorne MA
    Diabetes Obes Metab; 2005 Mar; 7(2):170-81. PubMed ID: 15715890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dipeptidyl peptidase IV-resistant [D-Ala(2)]glucose-dependent insulinotropic polypeptide (GIP) improves glucose tolerance in normal and obese diabetic rats.
    Hinke SA; Gelling RW; Pederson RA; Manhart S; Nian C; Demuth HU; McIntosh CH
    Diabetes; 2002 Mar; 51(3):652-61. PubMed ID: 11872663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of capsaicin-sensitive nerves in the regulation of glucose tolerance in diabetic rats.
    Guillot E; Coste A; Angel I
    Life Sci; 1996; 59(12):969-77. PubMed ID: 8809210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of dipeptidyl peptidase IV with NVP-DPP728 increases plasma GLP-1 (7-36 amide) concentrations and improves oral glucose tolerance in obese Zucker rats.
    Balkan B; Kwasnik L; Miserendino R; Holst JJ; Li X
    Diabetologia; 1999 Nov; 42(11):1324-31. PubMed ID: 10550416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Capsaicin-sensitive sensory fibers in the islets of Langerhans contribute to defective insulin secretion in Zucker diabetic rat, an animal model for some aspects of human type 2 diabetes.
    Gram DX; Ahrén B; Nagy I; Olsen UB; Brand CL; Sundler F; Tabanera R; Svendsen O; Carr RD; Santha P; Wierup N; Hansen AJ
    Eur J Neurosci; 2007 Jan; 25(1):213-23. PubMed ID: 17241282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of the dipeptidyl peptidase IV inhibitor isoleucine thiazolidide (P32/98) in fatty Zucker rats with incipient and manifest impaired glucose tolerance.
    Augstein P; Berg S; Heinke P; Altmann S; Salzsieder E; Demuth HU; Freyse EJ
    Diabetes Obes Metab; 2008 Sep; 10(10):850-61. PubMed ID: 17970756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered dipeptidyl peptidase-4 activity during the progression of hyperinsulinemic obesity and islet atrophy in spontaneously late-stage type 2 diabetic rats.
    Kirino Y; Sato Y; Kamimoto T; Kawazoe K; Minakuchi K
    Am J Physiol Endocrinol Metab; 2011 Feb; 300(2):E372-9. PubMed ID: 21139073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. (2S,4S)-4-Fluoro-1-{[(2-hydroxy-1,1-dimethylethyl)amino]acetyl}-pyrrolidine-2-carbonitrile monobenzenesulfonate (TS-021) is a selective and reversible dipeptidyl peptidase IV inhibitor.
    Tajima A; Yamamoto K; Kozakai A; Okumura-Kitajima L; Mita Y; Kitano K; Jingu S; Nakaike S
    Eur J Pharmacol; 2011 Mar; 655(1-3):99-107. PubMed ID: 21262219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of dipeptidyl peptidase-IV activity by metformin enhances the antidiabetic effects of glucagon-like peptide-1.
    Green BD; Irwin N; Duffy NA; Gault VA; O'harte FP; Flatt PR
    Eur J Pharmacol; 2006 Oct; 547(1-3):192-9. PubMed ID: 16945366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel, potent, and long-lasting dipeptidyl peptidase-4 inhibitor, teneligliptin, improves postprandial hyperglycemia and dyslipidemia after single and repeated administrations.
    Fukuda-Tsuru S; Anabuki J; Abe Y; Yoshida K; Ishii S
    Eur J Pharmacol; 2012 Dec; 696(1-3):194-202. PubMed ID: 23022337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improvement of glycemic control in streptozotocin-induced diabetic rats by Atlantic salmon skin gelatin hydrolysate as the dipeptidyl-peptidase IV inhibitor.
    Hsieh CH; Wang TY; Hung CC; Chen MC; Hsu KC
    Food Funct; 2015 Jun; 6(6):1887-92. PubMed ID: 25946069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenoviral vector-mediated glucagon-like peptide 1 gene therapy improves glucose homeostasis in Zucker diabetic fatty rats.
    Lee Y; Kwon MK; Kang ES; Park YM; Choi SH; Ahn CW; Kim KS; Park CW; Cha BS; Kim SW; Sung JK; Lee EJ; Lee HC
    J Gene Med; 2008 Mar; 10(3):260-8. PubMed ID: 18085721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved glucose tolerance in Zucker fatty rats by oral administration of the dipeptidyl peptidase IV inhibitor isoleucine thiazolidide.
    Pederson RA; White HA; Schlenzig D; Pauly RP; McIntosh CH; Demuth HU
    Diabetes; 1998 Aug; 47(8):1253-8. PubMed ID: 9703325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ablation of capsaicin-sensitive afferent nerves affects insulin response during an intravenous glucose tolerance test.
    van de Wall EH; Gram DX; Strubbe JH; Scheurink AJ; Koolhaas JM
    Life Sci; 2005 Jul; 77(11):1283-92. PubMed ID: 15939440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of long-term treatment with the dipeptidyl peptidase-4 inhibitor vildagliptin on islet endocrine cells in non-obese type 2 diabetic Goto-Kakizaki rats.
    Inaba W; Mizukami H; Kamata K; Takahashi K; Tsuboi K; Yagihashi S
    Eur J Pharmacol; 2012 Sep; 691(1-3):297-306. PubMed ID: 22820107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of TNF-α blocking on experimental periodontitis and type 2 diabetes in obese diabetic Zucker rats.
    Grauballe MB; Østergaard JA; Schou S; Flyvbjerg A; Holmstrup P
    J Clin Periodontol; 2015 Sep; 42(9):807-816. PubMed ID: 26257165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.